Cargando…
PHACTR1 is associated with disease progression in Chinese Moyamoya disease
Moyamoya disease (MMD) is a progressive stenosis at the terminal portion of internal carotid artery and frequently occurs in East Asian countries. The etiology of MMD is still largely unknown. We performed a case-control design with whole-exome sequencing analysis on 31 sporadic MMD patients and 10...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207206/ https://www.ncbi.nlm.nih.gov/pubmed/32411507 http://dx.doi.org/10.7717/peerj.8841 |
_version_ | 1783530554200686592 |
---|---|
author | Yang, Yongbo Wang, Jian Liang, Qun Wang, Yi Chen, Xinhua Zhang, Qingrong Na, Shijie Liu, Yi Yan, Ting Hang, Chunhua Zhu, Yichao |
author_facet | Yang, Yongbo Wang, Jian Liang, Qun Wang, Yi Chen, Xinhua Zhang, Qingrong Na, Shijie Liu, Yi Yan, Ting Hang, Chunhua Zhu, Yichao |
author_sort | Yang, Yongbo |
collection | PubMed |
description | Moyamoya disease (MMD) is a progressive stenosis at the terminal portion of internal carotid artery and frequently occurs in East Asian countries. The etiology of MMD is still largely unknown. We performed a case-control design with whole-exome sequencing analysis on 31 sporadic MMD patients and 10 normal controls with matched age and gender. Patients clinically diagnosed with MMD was determined by digital subtraction angiography (DSA). Twelve predisposing mutations on seven genes associated with the sporadic MMD patients of Chinese ancestry (CCER2, HLA-DRB1, NSD-1, PDGFRB, PHACTR1, POGLUT1, and RNF213) were identified, of which eight single nucleotide variants (SNVs) were deleterious with CADD PHRED scaled score > 15. Sanger sequencing of nine cases with disease progression and 22 stable MMD cases validated that SNV (c.13185159G>T, p.V265L) on PHACTR1 was highly associated with the disease progression of MMD. Finally, we knocked down the expression of PHACTR1 by transfection with siRNA and measured the cell survival of human coronary artery endothelial cell (HCAEC) cells. PHACTR1 silence reduced the cell survival of HCAEC cells under serum starvation cultural condition. Together, these data identify novel predisposing mutations associated with MMD and reveal a requirement for PHACTR1 in mediating cell survival of endothelial cells. |
format | Online Article Text |
id | pubmed-7207206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72072062020-05-14 PHACTR1 is associated with disease progression in Chinese Moyamoya disease Yang, Yongbo Wang, Jian Liang, Qun Wang, Yi Chen, Xinhua Zhang, Qingrong Na, Shijie Liu, Yi Yan, Ting Hang, Chunhua Zhu, Yichao PeerJ Cell Biology Moyamoya disease (MMD) is a progressive stenosis at the terminal portion of internal carotid artery and frequently occurs in East Asian countries. The etiology of MMD is still largely unknown. We performed a case-control design with whole-exome sequencing analysis on 31 sporadic MMD patients and 10 normal controls with matched age and gender. Patients clinically diagnosed with MMD was determined by digital subtraction angiography (DSA). Twelve predisposing mutations on seven genes associated with the sporadic MMD patients of Chinese ancestry (CCER2, HLA-DRB1, NSD-1, PDGFRB, PHACTR1, POGLUT1, and RNF213) were identified, of which eight single nucleotide variants (SNVs) were deleterious with CADD PHRED scaled score > 15. Sanger sequencing of nine cases with disease progression and 22 stable MMD cases validated that SNV (c.13185159G>T, p.V265L) on PHACTR1 was highly associated with the disease progression of MMD. Finally, we knocked down the expression of PHACTR1 by transfection with siRNA and measured the cell survival of human coronary artery endothelial cell (HCAEC) cells. PHACTR1 silence reduced the cell survival of HCAEC cells under serum starvation cultural condition. Together, these data identify novel predisposing mutations associated with MMD and reveal a requirement for PHACTR1 in mediating cell survival of endothelial cells. PeerJ Inc. 2020-05-05 /pmc/articles/PMC7207206/ /pubmed/32411507 http://dx.doi.org/10.7717/peerj.8841 Text en ©2020 Yang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Cell Biology Yang, Yongbo Wang, Jian Liang, Qun Wang, Yi Chen, Xinhua Zhang, Qingrong Na, Shijie Liu, Yi Yan, Ting Hang, Chunhua Zhu, Yichao PHACTR1 is associated with disease progression in Chinese Moyamoya disease |
title | PHACTR1 is associated with disease progression in Chinese Moyamoya disease |
title_full | PHACTR1 is associated with disease progression in Chinese Moyamoya disease |
title_fullStr | PHACTR1 is associated with disease progression in Chinese Moyamoya disease |
title_full_unstemmed | PHACTR1 is associated with disease progression in Chinese Moyamoya disease |
title_short | PHACTR1 is associated with disease progression in Chinese Moyamoya disease |
title_sort | phactr1 is associated with disease progression in chinese moyamoya disease |
topic | Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207206/ https://www.ncbi.nlm.nih.gov/pubmed/32411507 http://dx.doi.org/10.7717/peerj.8841 |
work_keys_str_mv | AT yangyongbo phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT wangjian phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT liangqun phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT wangyi phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT chenxinhua phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT zhangqingrong phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT nashijie phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT liuyi phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT yanting phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT hangchunhua phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease AT zhuyichao phactr1isassociatedwithdiseaseprogressioninchinesemoyamoyadisease |